ArticleAdvances in therapy2026
Clinical Characteristics and Patient Burden of Cluster Headache in Brazil: A Real-World Study.
Article in Advances in therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCluster headache (CH) is a debilitating condition with health-related and economic burden to patients, including reduced quality of life (QoL) and suicidality. Brazilian data on comorbidities, symptoms, or impact on QoL and productivity remain limited. This study aims to assess CH's impact on patients' QoL, overall health, and employment in Brazil from physicians' and patients' perspectives.
methodsData were extracted from the Adelphi Real World CH Disease Specific Programme™, a real-world, cross-sectional survey of physicians and their patients with CH in Brazil from November 2021-July 2022. Physicians reported on demographics, clinical characteristics, comorbidities, and suicidality. Patients reported CH's impact on feelings/reactions, suicidality, employment using the Work Productivity and Activity Impairment questionnaire, and QoL using the EuroQol 5 Dimension 5 Level survey. Data analyses were conducted with R Statistical software (v4.1.2).
resultsPatients completed 177 forms, while physicians completed 450 forms. Patients had episodic CH (ECH, n = 355) and chronic CH (CCH, n = 95). Common comorbidities were anxiety, insomnia, hypertension, depression, and dyslipidemia. Stress and lack of sleep were key physician-reported CH triggers, and 10.34% of patients had considered suicide. The presence of CH may have led to absenteeism (11.45%) and presenteeism (30.08% overall work impairment, 29.38% activity impairment, and 29.36% impairment while working).
conclusionsCH carries a significant disease burden and negative socioeconomic impact, especially among patients with CCH. Stress was the most common trigger for both attacks and bouts with notable rates of suicidality. This indicates a need among physicians and patients for targeted and more efficacious interventions to reduce CH's burden, improving patients' QoL.
Indexed as
Identifiers
41335330What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.